Cannabis Law Report

OCTOBER 12, 2021

–(BUSINESS WIRE)– $APDN #covid19 — Applied DNA Sciences, Inc. Leveraging its deep expertise in nucleic acid-based technologies, the Company has also established safeCircle™, a pooled COVID-19 testing program that is grounded in the Company’s EUA-authorized Linea™ COVID-19 Assay Kit. STONY BROOK, N.Y.–(BUSINESS

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Orphan drug designation provides certain benefits, including market exclusivity upon regulatory approval, if received, exemption of FDA application fees and tax credits for qualified clinical trials. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

MAY 29, 2022

Businesses have been recently receiving approval from Health Canada to farm psychedelic mushrooms, make psilocybin and sell the compound to drug-makers, or to doctors to give to patients. The psilocybin mushrooms are headed to clinical trials, drug companies and medical facilities. “I’m

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

MMJ Recs

APRIL 1, 2024

Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

JULY 28, 2021

MAPS Public Benefit Corporation (MAPS PBC) catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit. MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment.

Clinical Trials 105

Clinical Trials Research and Development Data Environment 105

Cannabis Law Report

JULY 24, 2021

“At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer. Mydecine has also successfully completed multiple acquisitions since its inception. For more information, please contact: Media Contacts.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Position Requirements.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 2, 2021

– Company’s safeCircle™ Testing Program to Monitor for COVID-19 Among On-Campus Unvaccinated Populations –. –(BUSINESS WIRE)– $APDN #COVID19Testing — Applied DNA Sciences, Inc. STONY BROOK, N.Y.–(BUSINESS The College’s student population comprises about 25,000 full- and part-time students.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

MARCH 29, 2022

Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA. Dawn remains a faculty member at Penn directing the QA course of study for the ITMAT Masters program.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Program between St. Yet we know how expensive college can be.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

AUGUST 3, 2021

– Full Service, Turnkey Solution Anchored by Applied DNA Clinical Labs’ safeCircle™ Pooled COVID-19 Testing to Be Deployed Across All 25 CUNY Campuses to Facilitate Fall Re-Opening –. –(BUSINESS WIRE)– $APDN #COVID19 — Applied DNA Sciences, Inc. million, and contains no minimum weekly testing commitment.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science. On a Trip: LSD (Lysergic Acid Diethylamide).

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Cannabis Law Report

DECEMBER 21, 2021

Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. While its psilocybin and MDMA trials progress, the company is expanding its psychedelics research laboratory.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

MARCH 3, 2022

If everything works out in the production and research phase, there is a clause in the license that will allow it to be expanded to clinical trials. The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. This would add to the wave of research beginning in the U.S. and Europe. ” Hon.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. I am thrilled to have Patricia, Steve, Julie and Dewey join us to help accelerate our capabilities across these key functions,” said Dr. Drake received her bachelor’s degree from Wichita State University and is a graduate of the Harvard Business School Executive Leadership Program.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

DECEMBER 21, 2021

. SAN DIEGO–(BUSINESS WIRE)– $DFCO #CleanEnergy — Dalrada Corporation (OTCQB: DFCO , “Dalrada”) would like to express its sincere appreciation for its investors, shareholders, staff and followers for their support throughout 2021. billion in 2020 (Grandview Research). from 2021 to 2028.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

JANUARY 20, 2022

Business combination with Silver Spike Acquisition Corp. Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Currently, its managed clinics provide access to FDA-approved drug therapies like SPRAVATO (esketamine).

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. There’s now pressure in the industry to downplay the negative stories by those who stand to profit from the business of psychedelics.

Medicine 52

Medicine Therapy Research and Development Business 52

Cannabis Law Report

APRIL 13, 2022

Complementary businesses combine to create a preeminent North American platform with operations spanning 13 wellness clinics, four research sites and one bioanalytical laboratory. Creates an industry-leading North American platform for psychedelic clinics and clinical research. Apr 12, 2022, 07:00 ET.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

JANUARY 9, 2019

Tindall was helping turnaround a business using his decades of experience in financial services, and also coming to terms with the death of his own father, when he had an awakening as to what medicinal cannabis was capable of. “We Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

NOVEMBER 13, 2019

Denmark’s pilot pharma trial attracts first-movers. Europe is open for business, and Denmark wants to be the first-mover. Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. By Arundati Dandapani. Arundati Dandapani.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

The Cannigma

MAY 7, 2021

In today’s episode, we speak with Stephen Murphy, co-founder and CEO of Prohibition Partners, a cannabis-focused business intelligence and consultancy company. The Cannabis Enigma podcast is a co-production of The Cannigma and Americans for Safe Access. Executive producer, Michael Schaeffer Omer-Man. Music by Desca.

Supply Chain 120

Supply Chain Patients Access Hemp 120

Cannabis Law Report

FEBRUARY 3, 2022

KFAR SABA, Israel–(BUSINESS WIRE)– MediCane Health Inc. Together with its wide network of research partners, MediCane is executing clinical programs to develop cannabis-based drugs with two leading therapeutic areas – Behavioral and Psychological Symptoms of Dementia (BPSD) and sleep disorders.

Clinical Trials 52

Clinical Trials Research and Development Packaging Oil 52

The Cannigma

MARCH 12, 2021

At the end of the episode, Debbie Churgai, executive director of Americans for Safe Access, discusses the various ways that military veterans — who could very much benefit from medical cannabis — have difficulty accessing it and the ways that the Veterans Administration can address that issue. Produced by Michael Schaeffer Omer-Man.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers. Growing operations.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

AUGUST 30, 2019

This week: The National Credit Union Administration affirms that credit unions may provide financial services to hemp businesses. Five federal financial regulatory agencies replied to a request for clarification from Senator Michael Bennet (D-CO) regarding the availability of banking services to hemp businesses.

Banking 45

Banking Research and Development Legislation Programs 45

SMPL

MAY 26, 2020

Police raids and federal prosecution of medical marijuana businesses were still common. In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At We were in communication for many years.”.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

WeedAdvisor

AUGUST 3, 2019

Brazilian health officials want to pass ground-breaking legislation that would allow for medical marijuana to be grown locally, in addition to permit the sale of cannabis products that are still being studied, reports Marijuana Business Daily. However, the idea faces very fierce and influential opposition. Benefits. .

Clinical Trials 51

Clinical Trials Cultivation Legislation Cannabis 51

The Cannigma

DECEMBER 22, 2021

Today’s guest is Itai Rogel, the Vice President of Business Development at Israeli cannabis company, Bazelet. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. I recorded the VP of business development from an Israeli cannabis company called Bazelet. Music by Desca. Have a listen after Itai.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. He is the founder of Apeiron Investment Group, his family office and merchant banking business. Rick Doblin, Ph.D, in/brand-florian/.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

JULY 21, 2022

By decriminalizing cannabis at the federal level, the CAOA also ensures that state-legal cannabis businesses or those in adjacent industries will no longer be denied access to bank accounts or financial services simply because of their ties to cannabis. Cannabis legalization is here, and Congress needs to get with the program.”

Safety 52

Safety Legislation Clinical Trials Banking 52

SpeedWeed

DECEMBER 28, 2018

billion dollars in the weed business ( f**k!). Bummer: Patients Are Still Struggling for Cannabis Access. Buzz: Cannabis Equity Programs Expand Opportunities. He qualified for the equity program based on a previous felony conviction, and having lived in a neighborhood disproportionately targeted for cannabis arrests.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

OCTOBER 17, 2019

But the global legal landscape is confusing and constantly evolving, making it essential for people and businesses around the world to secure strong legal representation. There are also ancillary businesses that have shown immense growth,” says Gil Selinger , a lawyer at Fairfield and Woods, P.C. (Denver, Colorado, USA).

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

DECEMBER 30, 2019

Illinois and the US territory of Guam legalized adult-use cannabis and its retail sale, medical cannabis programs were enacted and expanded in several states, and 27 states considered legislation that would have legalized adult-use cannabis, a record-high. House Committee on Small Business Highlights Need for Federal Reforms.

Legislation 59

Legislation Patients Access Banking 59